Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001730703-26-000002

Options or other derivatives

  • Director acquired 31,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kapur Anil Director 2026-05-15 Grant or award · Director Stock Option (right to buy) +31,250 31,250 D: show line 1 in the form
Loading xslF345X06/wk-form4_1778881743.xml…